Krazati Prices, Coupons and Patient Assistance Programs
Krazati (adagrasib) is a member of the miscellaneous antineoplastics drug class and is commonly used for Non Small Cell Lung Cancer.
The cost for Krazati oral tablet 200 mg is around $23,333 for a supply of 180 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Krazati is available as a brand name drug only, a generic version is not yet available. View generic Krazati availability for more details.
Krazati prices
Oral Tablet
Quantity | Per unit | Price |
---|---|---|
180 | $129.63 | $23,332.66 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Krazati Coupons, Copay Cards and Rebates
Krazati offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Krazati Mirati & Me Financial Support
Eligible commercially patients pay as little as $0 per prescription; for additional information contact the program at 844-647-2842.
- Applies to:
- Krazati
- Number of uses:
- Per prescription until program expires
Form more information phone: 844-647-2842 or Visit website
Krazati Mirati & Me Free Trial Offer
Eligible patients may recevie a free 30-day supply of medication; this is a one-time offer per patient per lifetime; for additional information contact the program at 844-647-2842.
- Applies to:
- Krazati
- Number of uses:
- One-time offer
Form more information phone: 844-647-2842 or Visit website
Krazati Mirati & Me Bridge Program
Eligible commercially insured patients experiencing a lapse in insurance coverage may be able to receive financial assistance for an appropriate supply of medication; for additional information contact the program at 844-647-2842.
- Applies to:
- Krazati
- Number of uses:
- Temporary Assistance
Form more information phone: 844-647-2842 or Visit website
Krazati Mirati & Me Quick Start Program
Eligible commercially insured patients experiencing a delay in insurance coverage may be able to receive financial assistance for an appropriate supply of medication; for additional information contact the program at 844-647-2842.
- Applies to:
- Krazati
- Number of uses:
- Temporary Assistance
Form more information phone: 844-647-2842 or Visit website
Patient Assistance & Copay Programs for Krazati
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance.Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Krazati (adagrasib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Mirati & Me Patient Support Program
Eligibility requirements:- Determined case by case
- Based on FPL
- FDA-approved diagnosis
- Must reside in the US and be under the direct care of a US physician
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.Free Trial Program: Contact Program for details.This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Krazati (adagrasib) Tablet
More information please phone: 844-647-2842 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Krazati (adagrasib)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español